Gilead

CAR T-cell cancer therapies for patients with blood cancers, developed by Kite, a Gilead company

+ Add to sales board

Highlights

  • Hiring5 open roles
  • New on EvolcAdded 2026-10-28

About Gilead

Kite develops and commercialises CAR T-cell therapies, a custom-made one-time treatment that engineers a patient's own white blood cells to treat certain blood cancers. Its marketed products include YESCARTA (axicabtagene ciloleucel) and TECARTUS (brexucabtagene autoleucel), and its pipeline covers other cell therapy modalities.

Kite is a Gilead Sciences company, acquired in October 2017 and operated as an independent operating company since 2019. Its revenue comes from sales of its approved cell therapies to patients and healthcare providers. The company lists its manufacturing site in El Segundo, California, which opened in 2016.

Kite was founded in 2009, and its website lists offices and operations in the United States and Amsterdam. Current job openings span regulatory, clinical development, process engineering, medical affairs, and sales roles in the United States, the Netherlands and the United Kingdom.

Product: CAR T-cell therapies YESCARTA (axicabtagene ciloleucel) and TECARTUS (brexucabtagene autoleucel) for certain blood cancers.

Jobs at Gilead (5)

Gilead is hiring for 5 roles, mostly in manufacturing and legal, based in Hoofddorp, Amsterdam and London.

More biotech & pharma companies

  • Gilead

    Biopharmaceutical company developing and supplying medicines in virology, oncology and inflammation for patients worldwide
    Foster City, United StatesBiotech & pharma43 open jobs
    New on Evolc
  • Hansa Biopharma

    Develops antibody-cleaving enzyme medicines for patients with rare immune-mediated diseases and transplant desensitisation
    United StatesBiotech & pharma2 open jobs
  • HAYA Therapeutics

    Develops RNA-guided medicines that target non-coding RNAs in disease, with Eli Lilly as a collaboration partner
    United StatesBiotech & pharma1 open job
  • Iambic Therapeutics

    AI-enabled drug discovery and therapeutic development for patients and pharmaceutical partners
    United StatesBiotech & pharma1 open job
    Remote-friendly
  • Illumina

    DNA sequencing, microarray, and genomics software solutions for researchers, clinicians, and laboratories
    United StatesBiotech & pharma7 open jobs
    New on EvolcRemote-friendlySalary transparent
  • Immunic Therapeutics

    Develops oral small-molecule therapies for patients with neurologic, inflammatory and autoimmune diseases
    United StatesBiotech & pharma2 open jobs
    Salary transparent

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • ASP.NET
  • Cloudflare
  • Google Tag Manager
  • jQuery